PCLAF and skin disorder: Supporting this supposition, inhibition of the PAF degradative enzyme, PLA2G7, exacerbated dermatitis, vascular leak and neutrophil infiltration while depletion of basophils, a major cellular source of PAF, ameliorated disease (Figure 4).